Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Vaccine|January 21, 2023
A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic countryVianney Tricou, Susannah Eyre, Mahadev Ramjee, et al.
The Journal of Antimicrobial Chemotherapy|June 17, 2008
Low prevalence of transmitted antiretroviral drug resistance in a large UK HIV-1 cohortBrendan A I Payne, Emmanuel F Nsutebu, Ewan R Hunter, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2025
Air and surface sampling for clade Ib monkeypox virus in United Kingdom hospitals, 2024 to 2025Barry Atkinson, Susan Gould, Ian Nicholls, et al.
NPJ Digital Medicine|December 22, 2023
Unsupervised machine learning to investigate trajectory patterns of COVID-19 symptoms and physical activity measured via the MyHeart Counts App and smart devicesVarsha Gupta, Sokratis Kariotis, Mohammed D Rajab, et al.
American Journal of Respiratory and Critical Care Medicine|May 31, 2017
Impaired Mitochondrial Microbicidal Responses in Chronic Obstructive Pulmonary Disease MacrophagesMartin A Bewley, Julie A Preston, Mohammed Mohasin, et al.
BMJ Open|February 5, 2026
Multiarm multistage randomised controlled trial of inflammatory signal inhibitors (MATIS) for patients hospitalised with COVID-19 pneumonia during the UK pandemicLorna Hazell, Clio Pillay, Victoria Cornelius, et al.
Jac-Antimicrobial Resistance|July 5, 2021
Consensus-based antimicrobial resistance and stewardship competencies for UK undergraduate medical studentsDavid McMaster, Molly Courtenay, Catherine Santucci, et al.
American Journal of Respiratory and Critical Care Medicine|March 17, 2018
Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease Is Enhanced by Nrf2 AgonistsMartin A Bewley, Richard C Budd, Eilise Ryan, et al.
Cell Host & Microbe|December 11, 2020
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to NeutralizationDrew Weissman, Mohamad-Gabriel Alameh, Thushan de Silva, et al.
Nature Communications|January 31, 2024
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial, Peter W Horby, Leon Peto, et al.
Pageof 3